So you're looking at the retatrutide pen for research setups, and the first thing to check is really how tight the batch-to-batch consistency is on the adjustability—the 0.01 to 0.6ml dose range sounds flexible, but we've seen some setups struggle when moving between those extremes, so we test at both ends.

We basically run each device through a ≤6 second injection time protocol, and what that means for your work is you get that controlled dilevery you need for GLP-1 or HCG formulations without the hassle of syringes.

The 31G and 32G needle compatiblity—those are standard for this type of application, and we usually supply a 50-unit or so bulk order with a COA attached, but confirm teh MOQ because it varies with customization like branding or cartridge specifics.

Now, certification-wise, it's China Class II Medical Device, and that pharmaceutical-grade plastic holds up well under repeated use, though it's really important to note this isn't suited for human therapeutic use—we cover that in the SDS, always sent with every order along with batch data.

The retest policy we've got is pretty straightforward: if the HPLC or the injection time sensors flag anything off in the initial batch sample, we'll run a retest within 20 days or so from your order date.

Anyway, most buyers go with the 3ml capasity because of that it balances dosing flexibility and cartridge changes, but that φ9.7mm diameter means you're locked into specific cartridges—something we usually confirm during bulk customization process, just a heads up.